VOGLIGOLD M 0.3
Item requires a valid prescription
Manufactured By Steris Healthcare Pvt Ltd
Composition Voglibose 0.3 mg And Metformin Hydrochloride (SR) 500 mg Tablets
Rs 78.09
MRP Rs 111.55
(30% OFF)
Includes all taxes
Package SIZE
( For 15 Tablets )
100% Authentic
Products
Free
Shipping*
Products
Return Policy
Description:
Many people with type 2 diabetes in India follow their doctor’s advice, watch their sweets and still see surprising numbers on the glucometer. The fasting reading looks fine, but two hours after a thali of rice, roti and dal the sugar jumps. Others find that their sugar rises through the night or early morning because the effect of an earlier dose has worn off. VOGLIGOLD M 0.3 from Steris Healthcare Pvt. Ltd. is designed with both problems in mind. It combines voglibose 0.3 mg, which softens the post-meal rise, with metformin hydrochloride 500 mg in a sustained-release (SR) form, which provides steadier, longer-lasting action. This guide explains what the tablet contains, why it matters, its benefits, precautions and side effects, and how to buy it safely.
Product Information
Brand Name: VOGLIGOLD M 0.3
Composition: Voglibose 0.3 mg + Metformin Hydrochloride (SR) 500 mg
Manufacturer/Marketer: Steris Healthcare Pvt. Ltd.
Dosage Form: Tablet (the metformin component is sustained release)
Pack Size: 15 tablets
Drug Classes: Alpha-glucosidase inhibitor + biguanide
Therapeutic Category: Anti-diabetic (oral combination therapy)
Prescription Status: Prescription required (Rx)
Primary Use: Management of type 2 diabetes mellitus in adults when blood sugar is not adequately controlled with diet, exercise and a single agent
Target Market: India
Please check the printed label and leaflet on your pack for the batch number, manufacturing and expiry dates, MRP and storage instructions. Prices vary by pharmacy and location, so confirm the current price at the time of purchase.
What Is VOGLIGOLD M 0.3?
VOGLIGOLD M 0.3 is a fixed-dose combination of two anti-diabetic medicines that complement each other.
Voglibose (0.3 mg) is an alpha-glucosidase inhibitor. It works inside the small intestine, where it temporarily slows the enzymes that break complex carbohydrates down into glucose. Sugar from your meal therefore enters the blood more slowly, which reduces the sharp post-meal peak. Voglibose acts mainly in the gut, and very little is absorbed into the bloodstream.
Metformin Hydrochloride SR (500 mg) is a biguanide, the most widely used first-line medicine for type 2 diabetes. It reduces the amount of glucose released by the liver and helps muscle and fat tissue respond better to insulin. The sustained-release form releases the drug gradually over several hours rather than all at once. For many people, this means smoother blood levels and, in some cases, better stomach tolerance than immediate-release metformin.
Neither ingredient forces the pancreas to release extra insulin. As a result, the combination generally carries a low risk of hypoglycaemia when used on its own.
Why It Is Important
1. It addresses two different problems at once. Metformin works on fasting glucose and insulin resistance, while voglibose works on the glucose surge that follows food. Used together, they cover more of the day.
2. Post-meal spikes carry long-term risk. Repeated high readings after meals can contribute to damage in the eyes, kidneys, nerves and blood vessels over time. Controlling them is an important part of bringing HbA1c into range.
3. It fits carbohydrate-heavy Indian diets. Rice, wheat, potatoes, sweets and snacks make up a large share of daily calories for many families, so a medicine that slows carbohydrate absorption is especially relevant.
4. Sustained release supports steady control. The SR metformin component is designed to act over a longer period, which may help keep glucose levels more even between doses.
5. It can improve adherence. Chronic conditions are easier to manage when the routine is simple. One tablet that replaces two separate medicines can reduce missed doses.
6. It generally avoids the weight gain and frequent low sugars associated with some other drug classes. This can matter for people who are overweight, elderly or who eat at irregular times, though your doctor will decide what is best for you.
7. It supports long-term complication prevention. Staying within your HbA1c target lowers the risk of neuropathy, retinopathy, kidney disease and cardiovascular problems.
Key Benefits
- Better control of post-meal glucose: Voglibose slows carbohydrate digestion and flattens glucose peaks.
- Lower fasting glucose: Metformin reduces glucose production by the liver.
- Improved insulin sensitivity: The body can use its own insulin more effectively.
- Smoother action with SR metformin: Gradual release may support steadier levels and can be gentler on the stomach for some people.
- Low risk of hypoglycaemia: Neither ingredient stimulates insulin secretion.
- Weight-friendly profile: Both agents are generally weight-neutral, and some patients lose a little weight on metformin.
- Convenience: Fewer tablets can make the daily routine simpler for working adults and older patients.
- Established ingredients: Both medicines have been used for many years in India and worldwide, so doctors have considerable experience with them.
- Flexible add-on option: If needed, your doctor can add another anti-diabetic medicine later.
No tablet works in isolation. The best results come when medicine is combined with a balanced diet, regular walking or exercise, adequate sleep and routine glucose monitoring.
How It Is Usually Taken
Your doctor will decide the dose and timing based on your blood sugar readings, kidney function, diet and other medicines. Voglibose works while food is being digested, so combinations like this are generally taken with or just before a meal. Metformin is also better tolerated with food.
Because the metformin in this tablet is sustained release, swallow it whole with water. Do not crush, chew or break it unless your doctor or the leaflet says it is acceptable, since this can release the drug too quickly and increase side effects. You may occasionally notice a soft residue of the tablet in your stool. This is the empty shell of an SR tablet and is not a cause for concern, though you can mention it to your doctor. If you skip a meal, ask your doctor whether you should also skip that dose. If you miss a dose, do not double up next time. Follow your prescription and the pack leaflet.
Precautions: What to Tell Your Doctor and Keep in Mind
Do not use this medicine if you:
- Have type 1 diabetes, diabetic ketoacidosis or diabetic coma
- Are allergic to voglibose, metformin or any other ingredient in the tablet
- Have severe kidney impairment or significant liver disease
- Have conditions that raise the risk of lactic acidosis, such as severe infection, dehydration, serious heart or lung failure, or heavy alcohol use
- Have intestinal obstruction, severe inflammatory bowel disease or chronic digestive disorders affecting digestion and absorption
Use with caution and under medical supervision if you:
- Are elderly
- Have mild to moderate kidney or liver problems
- Have had abdominal surgery or bowel problems
- Are scheduled for surgery or a scan using contrast dye, because metformin may need to be paused temporarily
- Are pregnant, planning pregnancy or breastfeeding, since your doctor will advise the safest option for you
- Take other medicines such as insulin, sulfonylureas, certain antibiotics, diuretics, steroids or herbal supplements, as these can change blood sugar levels or how the medicine works
Possible Side Effects
Most people tolerate this combination well, though side effects can occur, especially in the first few weeks.
Common side effects:
- Gas, flatulence and abdominal bloating (more typical with voglibose)
- Stomach discomfort or cramps
- Nausea, loose stools or diarrhoea
- Metallic taste in the mouth (metformin)
- Reduced appetite
Less common side effects:
- Mild headache or dizziness
- Constipation
- Skin rash or itching
- Vitamin B12 deficiency with long-term metformin use
- Changes in liver enzyme levels on blood tests
Many digestive symptoms settle as the body adjusts. If they persist or bother you, do not stop the medicine on your own. Talk to your doctor, who may adjust the dose or timing.
Frequently Asked Questions
1. What are voglibose 0.3 mg and metformin hydrochloride 500mg tablets?
Voglibose 0.3 mg and metformin hydrochloride 500 mg tablets are a fixed-dose combination anti-diabetic medicine used in adults with type 2 diabetes mellitus, along with a healthy diet and regular physical activity. Voglibose slows the digestion of carbohydrates in the small intestine, which reduces the rise in blood sugar after meals. Metformin lowers the amount of glucose released by the liver and improves the body’s response to insulin. In VOGLIGOLD M 0.3, the metformin is in a sustained-release (SR) form, which releases the drug gradually over several hours. Doctors commonly prescribe this combination when metformin alone does not control post-meal sugar adequately. It is a prescription-only medicine.
2. What is the composition of voglibose 0.3 mg and metformin hydrochloride 500mg tablets?
VOGLIGOLD M 0.3 contains:
- Voglibose 0.3 mg
- Metformin Hydrochloride (SR) 500 mg
Inactive ingredients (excipients) can differ between brands, so please check the pack label and leaflet for the complete composition.
3. Which company manufactures voglibose 0.3 mg and metformin hydrochloride 500mg tablets in India?
VOGLIGOLD M 0.3 is manufactured and marketed by Steris Healthcare Pvt. Ltd. Several other Indian pharmaceutical companies also sell this combination under their own brand names. Always confirm the manufacturer name, batch number and licence details printed on the pack.
4. Where can I find a supplier of voglibose 0.3 mg and metformin hydrochloride 500mg tablets?
You can source these tablets from:
- Licensed retail chemists and hospital pharmacies (for personal use with a valid prescription)
- Registered pharmaceutical wholesalers and distributors
- Licensed online pharmacies that display a valid drug licence number
- The manufacturer or its authorised marketing team, through official contact channels
Before ordering, verify the supplier’s drug licence, GST registration and physical address. Avoid sellers who do not ask for a prescription or cannot show valid licences.
5. How can I buy voglibose 0.3 mg and metformin hydrochloride 500mg tablets in bulk?
Bulk purchase is usually done through a licensed wholesaler or distributor, or directly from the manufacturer or its authorised channel. Pharmacies, hospitals, clinics and distributors generally need to provide:
- A valid wholesale or retail drug licence
- GST number and business details
- Required quantity and pack size (VOGLIGOLD M 0.3 comes in a pack of 15 tablets)
- Delivery location
Ask for a tax invoice showing batch numbers and expiry dates with every consignment. Individual patients should not stock up in bulk without medical advice, since the tablets expire and require a prescription.
6. What is the price of voglibose 0.3 mg and metformin hydrochloride 500mg tablets?
The price depends on the brand, pack size, pharmacy and location. VOGLIGOLD M 0.3 is available in a pack of 15 tablets, and the MRP printed on the pack is the maximum retail price. Wholesale rates and bulk discounts differ by supplier and order quantity. Please confirm the current price with the manufacturer, a licensed distributor or your local chemist, as prices can change.
7. Can pharmaceutical distributors order these tablets wholesale?
Yes, licensed distributors and wholesalers can generally place wholesale orders with the manufacturer or its authorised channels. You will typically need to share your wholesale drug licence, GST details and the territory you serve. Minimum order quantity, margins, credit terms and delivery timelines are set by the company, so contact the marketer directly to discuss them.
8. Which pharmaceutical companies offer third-party manufacturing for these tablets?
Many Indian contract and loan-licence manufacturers produce oral anti-diabetic tablets for other brands, especially in pharma hubs such as Baddi (Himachal Pradesh), Haridwar (Uttarakhand), Ahmedabad and Vadodara (Gujarat) and Hyderabad (Telangana). I cannot verify which specific companies currently offer this combination, so I recommend that you:
- Confirm the manufacturer holds a valid manufacturing licence and WHO-GMP or equivalent certification
- Ask about product-specific capability, including experience with sustained-release formulations, minimum order quantity, batch size and stability data
- Request regulatory documents and, where possible, audit the facility
- Check the combination’s approval status with the Indian drug regulator
Third-party manufacturing of prescription fixed-dose combinations must comply with CDSCO and state drug authority regulations.
9. How can I request a quotation for voglibose 0.3 mg and metformin hydrochloride 500mg tablets?
Contact the manufacturer or a licensed supplier through their official email, phone number or enquiry form, and include:
- Your company name and business type (distributor, pharmacy, hospital and so on)
- Drug licence and GST numbers
- Product name and composition (VOGLIGOLD M 0.3, Voglibose 0.3 mg and Metformin Hydrochloride SR 500 mg tablets)
- Pack size and required quantity
- Delivery location and expected timeline
Request the quotation in writing and ask for its validity period, payment terms and applicable taxes.
10. Where can I find the product specifications for these tablets?
Product specifications are available from:
- The pack label and the package insert inside the carton
- The manufacturer’s official website or product catalogue
- The marketer’s sales or regulatory team on request
- Your pharmacist or prescribing doctor
Key details to check include composition and strengths, dosage form (sustained-release tablet), pack size, storage conditions, shelf life, batch number and manufacturing and expiry dates. Institutional buyers and distributors can also ask the manufacturer for a product data sheet or certificate of analysis.